Pricing Log in Create free account
Friday 6 November 2026 Export HALO’s income statement to Excel — free account

Halozyme Therapeutics, Inc.

HALO Healthcare Biotechnology

Halozyme Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 37.6% from fiscal 2024.

Revenue
+39.2%
EPS
+45.6%
Free cash flow
−58.6%
Total debt
+115.1%

Quarter to September 2026, against a year earlier

104.06 18.90 −15.37%
Market cap
$14.0B
P/E
29.5×
Fwd P/E
17.9×
Dividend yield
—
F-score
5/9
Altman Z
3.46
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Halozyme Therapeutics, Inc. (HALO) Current ratio

Alert me on Current ratio

Halozyme Therapeutics, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 3.9×, down 0.8× from fiscal 2025 (4.7×). Over the past ten years it has ranged from 1.3× (fiscal 2020) to 7.9× (fiscal 2021); the current reading is higher than 45% of that period. That is below the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 4.7× (40.28%)
FY2024 7.8× 17.59%
FY2023 6.6× 17.43%
FY2022 5.7× (28.54%)
FY2021 7.9× 500.61%
FY2020 1.3× (79.25%)
FY2019 6.3× 121.53%
FY2018 2.9× (26.29%)
FY2017 3.9× (17.31%)
FY2016 4.7× 70.89%

Quarterly newest first

Period Current ratio Change
Sep 2026 3.9× 43.20%
Jun 2026 2.7× (1.91%)
Mar 2026 2.8× (40.74%)
Dec 2025 4.7× 193.60%
43 more quarters

Against its own ten years

Low 1.3× High 7.9×
Ten-year median 4.7×
Current reading's percentile 45

Current ratio against peers

Company Current ratio
KYMR Kymera Therapeutics, Inc. compare 11.1×
SMMT Summit Therapeutics PLC compare 7.0×
TECH Bio-Techne Corp compare 4.5×
HALO Halozyme Therapeutics, Inc. 3.9×
EXEL Exelixis, Inc. compare 3.2×
ASND Ascendis Pharma A/S compare 3.0×
BMRN BioMarin Pharmaceutical Inc. compare 2.4×
BBIO BridgeBio Pharma, Inc. compare 2.1×
JAZZ Jazz Pharmaceuticals PLC compare 1.8×
Biotechnology industry median 4.9×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on HALO